Based on drugstore.com price, 20 syringes of Lovenox cost $708.45, generic cost $533.13, so the discount to customers is 24.75%. Is another piece in the puzzle. We need to see actual script numbers. A huge amount of uncertainity as to what the sales numbers will actually be. MNTA says ~15% discount, but what will it really be? Most sales are in hospitals, so how long has S/A tied up the deals? Some patients and docs will be very slow to convert to generic, and others will move immediately. So is 30% of the market high, or will 50% be low? And the huge question is when will FDA move on Teva, and if it is approved, what effect will it have on pricing and market share? Questions, questions, questions.
Market Data 
Markets
AI
